Daniel R. Passeri, CEO and President at Cue Biopharma, Inc. (CUE), bought 1,600 shares at $11.97 ($19K) on 2018-06-29, disclosed to the SEC on 2018-06-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CUE | BUY | 2021-09-27 | $50K | — | Filing → |
| CUE | BUY | 2019-06-25 | $10K | — | Filing → |
| CUE | BUY | 2019-06-07 | $21K | — | Filing → |